CN113940388A - Additive for improving pet urinary calculus and preparation method and application thereof - Google Patents
Additive for improving pet urinary calculus and preparation method and application thereof Download PDFInfo
- Publication number
- CN113940388A CN113940388A CN202111197710.4A CN202111197710A CN113940388A CN 113940388 A CN113940388 A CN 113940388A CN 202111197710 A CN202111197710 A CN 202111197710A CN 113940388 A CN113940388 A CN 113940388A
- Authority
- CN
- China
- Prior art keywords
- additive
- acid
- pet
- calculus
- dog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000654 additive Substances 0.000 title claims abstract description 51
- 230000000996 additive effect Effects 0.000 title claims abstract description 49
- 208000009911 Urinary Calculi Diseases 0.000 title claims abstract description 28
- 206010007027 Calculus urinary Diseases 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title abstract description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 54
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000004310 lactic acid Substances 0.000 claims abstract description 18
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 18
- 150000004667 medium chain fatty acids Chemical class 0.000 claims abstract description 13
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 17
- 235000013305 food Nutrition 0.000 claims description 15
- 241000282326 Felis catus Species 0.000 claims description 13
- 239000005639 Lauric acid Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 4
- 239000002270 dispersing agent Substances 0.000 claims description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 4
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 3
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 239000012628 flowing agent Substances 0.000 claims description 2
- 229960002446 octanoic acid Drugs 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 abstract description 25
- 210000001635 urinary tract Anatomy 0.000 abstract description 18
- 240000005528 Arctium lappa Species 0.000 abstract description 15
- 235000003130 Arctium lappa Nutrition 0.000 abstract description 15
- 235000008078 Arctium minus Nutrition 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 11
- 229910052567 struvite Inorganic materials 0.000 abstract description 10
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 abstract description 8
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 6
- 230000002829 reductive effect Effects 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 239000004575 stone Substances 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 238000004090 dissolution Methods 0.000 abstract description 3
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 2
- 235000015165 citric acid Nutrition 0.000 abstract description 2
- 239000002934 diuretic Substances 0.000 abstract description 2
- 230000002686 anti-diuretic effect Effects 0.000 abstract 1
- 241000282472 Canis lupus familiaris Species 0.000 description 46
- 238000012360 testing method Methods 0.000 description 20
- 239000003795 chemical substances by application Substances 0.000 description 10
- 241000282465 Canis Species 0.000 description 8
- 230000020477 pH reduction Effects 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000013078 crystal Substances 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000002535 acidifier Substances 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- NQWVSMVXKMHKTF-JKSUJKDBSA-N (-)-Arctigenin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-JKSUJKDBSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- YYGRXNOXOVZIKE-UHFFFAOYSA-N Arctigenin Natural products COC1CCC(CC2COC(=O)C2CC3CCC(O)C(C3)OC)CC1OC YYGRXNOXOVZIKE-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- OIFFJDGSLVHPCW-UHFFFAOYSA-N Guayarol Natural products COc1ccc(CC2C(Cc3ccc(O)c(O)c3)COC2=O)cc1OC OIFFJDGSLVHPCW-UHFFFAOYSA-N 0.000 description 2
- NQWVSMVXKMHKTF-UHFFFAOYSA-N L-Arctigenin Natural products C1=C(OC)C(OC)=CC=C1CC1C(CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-UHFFFAOYSA-N 0.000 description 2
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- MXZRMHIULZDAKC-UHFFFAOYSA-L ammonium magnesium phosphate Chemical compound [NH4+].[Mg+2].[O-]P([O-])([O-])=O MXZRMHIULZDAKC-UHFFFAOYSA-L 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- NWFYESYCEQICQP-UHFFFAOYSA-N methylmatairesinol Natural products C1=C(OC)C(OC)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(OC)=C1 NWFYESYCEQICQP-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000008281 urolithiasis Diseases 0.000 description 2
- RVVLUQPXASICPK-UHFFFAOYSA-N 1-[5-(5-prop-1-ynylthiophen-2-yl)thiophen-2-yl]ethane-1,2-diol Chemical compound S1C(C#CC)=CC=C1C1=CC=C(C(O)CO)S1 RVVLUQPXASICPK-UHFFFAOYSA-N 0.000 description 1
- URQMEZRQHLCJKR-UHFFFAOYSA-N 3-Methyl-5-propyl-2-cyclohexen-1-one Chemical compound CCCC1CC(C)=CC(=O)C1 URQMEZRQHLCJKR-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 240000005859 Orthosiphon aristatus Species 0.000 description 1
- 244000248825 Peltandra virginica Species 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 206010064921 Urinary tract inflammation Diseases 0.000 description 1
- 208000012931 Urologic disease Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940095602 acidifiers Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- ZEAXBOPUTILUGH-UHFFFAOYSA-N aphyllocladine Natural products S1C(C#CC)=CC=C1C1=CC=C(C=O)S1 ZEAXBOPUTILUGH-UHFFFAOYSA-N 0.000 description 1
- BPYGTFFYYOWDBC-LOVSFRALSA-N arctiin Natural products COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc3ccc(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)cc1OC BPYGTFFYYOWDBC-LOVSFRALSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 208000022437 nephrolithiasis susceptibility caused by SLC26A1 Diseases 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/28—Silicates, e.g. perlites, zeolites or bentonites
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
Abstract
The invention relates to an additive for improving urinary calculus of pets, and a preparation method and application thereof. According to the invention, the burdock, medium-chain fatty acid, citric acid, lactic acid and other health functional substances in the urinary tract are made into additives, so that the additive is anti-inflammatory and diuretic, the pH value of urine is reduced to promote the dissolution of dog struvite, and the formation of pet struvite and calcium oxalate stones is reduced. The additive can be added into the pet daily ration in the form of a functional bag, and only 1-2% of the additive needs to be added into the pet daily ration, so that the effect of remarkably improving and preventing the problems of struvite and calcium oxalate stones of pets can be achieved.
Description
Technical Field
The invention belongs to the field of pet additives, and particularly relates to an additive for improving urinary calculus of pets, and a preparation method and application thereof.
Background
Urolithiasis is a common disease in pets, especially cats and dogs. Urinary calculus can cause dysuria, frequent micturition, odynuria, hematuria, urodriasis and the like, often accompanies inflammation, and seriously affects the health of pets. Urinary calculus is commonly struvite, i.e. struvite calculus and calcium oxalate calculus, which can be dissolved, and calcium oxalate calculus which cannot be dissolved. Pets of different varieties, sexes and ages are susceptible to calculus, and the recurrence rate is high. Therefore, the method is very important for helping crystallization and dissolution and controlling the recurrence of urinary calculus through daily ration nutrition. At present, the compatibility of Chinese herbal medicines for solving the calculus is researched more, but a scheme for solving the calculus in the urinary tract of a pet by controlling the acidity of urine and the urinary tract inflammation at the same time is not reported. The problem of inflammation in dogs and cats solved by using the burdock is not reported.
Patent document CN 103478496 a describes a urinary tract health maintenance nutritional health food for dogs and cats and a preparation method thereof. The health-care grain comprises the following components in percentage by mass: 10-30% of chicken, 10-50% of grain, 5-20% of vegetable protein, 5-20% of chicken fat, 5-15% of egg powder, 0.5-5% of tuckahoe, 0.5-5% of bighead atractylodes rhizome, 0.5-5% of plantain seed, 0.5-5% of rhizoma alismatis, 0.5-5% of akebiaquinata, 0.5-5% of rhizoma atractylodis, 0.5-5% of mangnolia officinalis, 0.5-5% of radix ophiopogonis, 0.5-5% of dried orange peel, 0.5-5% of liquorice, 1-5% of spinach, 1-5% of carrot, 0.5-5% of brewer's yeast, 0.2-0.5% of fructooligosaccharide, 0.5-5% of vitamin and 0.5-5% of mineral substance. Aiming at the induction reasons of the urinary tract diseases of dogs and cats, the invention starts with nutritional diet for maintaining the health of the urinary tract, and selects a full-nutritional special formula prepared from natural feedable plants to maintain the health of the urinary tract of dogs and cats. After feeding, the technology of the invention is effective for maintaining the health of the urinary tract of dogs and cats.
Patent document CN 112715751 a describes a urinary tract protection feed additive for dogs and cats and a preparation method thereof, comprising 10-40 parts by weight of a herba clerodendranthi spicati extract, 20-40 parts by weight of semen plantaginis, 5-10 parts by weight of turmeric powder and 40-60 parts by weight of a dispersant, wherein the dispersant is wheat bran. A preparation method of a urinary tract protection feed additive for dogs and cats comprises a) preparation of a Orthosiphon aristatus extract and b) mixing. When the additive is added at about 1%, the drinking water amount of dogs and cats can be obviously increased, the urine output and the urine output times are increased, and metabolic end products accumulated in serum are discharged, so that the nitrogen content of serum urea is obviously reduced, but the content of serum protein is not obviously changed, and the nitrogen balance of dogs and cats is not influenced.
Patent document CN 112790277a describes a food for preventing urinary calculus of pet dogs and a preparation method thereof. The food for preventing the urinary calculus of the pet dog comprises the following raw materials in parts by weight: 100-300 parts of bovine bone meal, 10-50 parts of fish meal, 20-35 parts of beet fiber, 1-5 parts of celery powder, 10-30 parts of carrot powder, 10-15 parts of soybean meal, 5-10 parts of dandelion powder, 1-5 parts of vitamin C and 1-5 parts of vitamin E. The pet dog food provided by the invention can effectively prevent initial formation of calcium oxalate urolithiasis of a pet dog, and further reduce the risk of the pet dog suffering from urolithiasis.
The composition adopts a Chinese herbal medicine scheme, has the main effect of promoting the urinary dilution of urine of pets, can prevent the generation of calculus by diluting the urine, and has no dissolving effect on the existing calculus or crystal. However, no technology for improving urinary calculus of pets, especially dogs and cats by using an acidifier is available in the existing reports. The invention uses the diuretic Chinese herbal medicines and combines with the acidified urine, not only can prevent the generation of new calculus, but also can dissolve the existing struvite crystals or calculus by continuously feeding.
Disclosure of Invention
The invention aims to solve the problems and provides an additive for improving pet urinary calculus and a preparation method and application thereof.
The purpose of the invention can be realized by the following scheme:
the invention provides an additive for improving urinary calculus of pets, which comprises the following components: citric acid, lactic acid, fructus Arctii, medium-chain fatty acid, and flowing agent.
As an embodiment of the invention, the additive comprises the following components in percentage by weight:
in the invention, the addition amount of citric acid and lactic acid is too small, urine acidification is not obvious, and the risk of excessive calcium oxalate calculus is increased. The burdock fruit has little addition amount and no diuretic effect, and can cause discomfort such as abdominal pain, diarrhea and the like when being too much. The addition amount of medium-chain fatty acid is small, the bacteriostatic action is avoided, and gastrointestinal mucosa discomfort can be caused by excessive addition. The addition amount of the flow agent is small, so that the flow agent cannot play a role in lubrication and dispersion, and the mouthfeel of animals is influenced too much.
As an embodiment of the invention, the medium-chain fatty acid is a fatty acid having 6 to 12 carbon atoms.
As an embodiment of the invention, the medium-chain fatty acid is one or more of lauric acid, caprylic acid, capric acid and caproic acid.
As an embodiment of the invention, the dispersant is silica. The flow agent is used as a carrier to fully mix the components, so that the components can be uniformly dispersed in the compound feed.
The invention also provides a preparation method of the additive, which comprises the following steps:
s1, weighing the components of the additive according to the proportion;
s2, mixing the components to obtain the additive for improving the urinary calculus of the pet.
As an embodiment of the invention, the mixing time is 15-30 min.
The invention also provides a pet food which contains the additive.
As one embodiment of the invention, the additive is used in an amount of 1-2% by weight of the pet food.
As an embodiment of the invention, the pet is a cat or a dog.
Compared with the prior art, the invention has the following beneficial effects:
1. the burdock is mainly used for promoting urination, diluting urine and reducing the probability of urine crystal formation. The medium-chain fatty acid is a substance with a strong bacteriostatic effect at present, is stable due to the selection of a glyceride form, is less influenced by PH, and has an effect superior to that of Chinese herbal medicine or plant extract products. The plant extract anti-inflammatory substance is easy to volatilize and lose in the processing process.
2. The acid of the invention can acidify urine, the PH value in the urinary tract is in a partial acid state, on one hand, struvite is dissolved, on the other hand, the invention can inhibit bacterial proliferation, and the acid and medium-chain fatty acid can play a role in synergistic bacteriostasis and anti-inflammation. Acidification of urine and inflammation control are not sufficient in urinary stone control, and inflammation aggravates calculus formation.
3. The additive of the invention relates to the problem of digestive absorption of animals, and needs the matching of two acidifiers, namely lactic acid and citric acid, to play a synergistic effect and release the acidifier to play a role in different parts of gastrointestinal tracts. Citric acid is more acidic than lactic acid, releases acid quickly, but has short duration, and mainly acts on stomach. The acidity of the lactic acid is released slower than that of the citric acid, the lactic acid and the citric acid mainly play a role in the intestinal tract, and the lactic acid and the citric acid are used cooperatively to achieve a good acidification effect in the whole digestion process. Other organic acids are used, the acidity is not suitable and can not be well released, the palatability of inorganic acids with strong acidity is poor, and pets can refuse to eat the pet food. The invention exerts the synergistic effect through the combination of lactic acid and citric acid, and achieves the same effect of acidification without influencing the palatability.
4. The functional substances with healthy urinary tracts such as burdock, medium-chain fatty acid, citric acid, lactic acid and the like are made into an additive functional bag and added into a full-value pet food formula according to 1% for feeding pets, so that the problems of urine acidification and urethritis of the pets are solved, and the remarkable effect of preventing struvite and calcium oxalate stones is achieved.
Drawings
Other features, objects and advantages of the invention will become more apparent upon reading of the detailed description of non-limiting embodiments with reference to the following drawings:
FIG. 1 is a comparison of the results of B-mode ultrasonography before and after the test in test No. 1 dog in test No. 2;
FIG. 2 is a graph showing a comparison of the conditions of the B-mode ultrasound before and after the test in dog No. 2 in test No. 2.
Detailed Description
The invention is described in detail below with reference to the figures and specific embodiments. The following examples, which are set forth to provide a detailed description of the invention and a detailed description of the operation, will help those skilled in the art to further understand the present invention. It should be noted that the scope of the present invention is not limited to the following embodiments, and that several modifications and improvements made on the premise of the idea of the present invention belong to the scope of the present invention.
And (3) burdock: is selected from dry mature fruit of Arctium lappa L of Compositae, and is rich in arctiin, arctigenin and arctinol. Researches show that the arctigenin has good bacteriostatic activity on staphylococcus aureus, escherichia coli, pseudomonas aeruginosa and candida albicans, and can effectively inhibit or block the release of inflammatory factors so as to play an anti-inflammatory role. Modern pharmacological research shows that the burdock has good effects of resisting inflammation, relieving fever and promoting urination.
Medium chain fatty acids: the lauric acid is selected from glycerol laurate, belongs to medium-chain fatty acid, and researches show that the lauric acid has good inhibitory effect on gram-positive bacteria and fungi.
Example 1
The embodiment provides an additive for improving canine urinary tract stones, which comprises the following components in parts by weight:
20% of citric acid;
20% of lactic acid;
10% of burdock;
20% of lauric acid;
30 percent of flow agent.
And (3) mixing the components of the additive weighed according to the proportion for 20min by a mixing machine to obtain the additive for improving the urinary calculus of the dog.
Example 2
The embodiment provides an additive for improving canine urinary tract stones, which comprises the following components in parts by weight:
30% of citric acid;
30% of lactic acid;
10% of burdock;
10% of lauric acid;
20 percent of flow agent.
And (3) mixing the components of the additive weighed according to the proportion for 20min by a mixing machine to obtain the additive for improving the urinary calculus of the dog.
Example 3
The embodiment provides an additive for improving canine urinary tract stones, which comprises the following components in parts by weight:
30% of citric acid;
10% of lactic acid;
20% of burdock;
10% of lauric acid;
30 percent of flow agent.
And (3) mixing the components of the additive weighed according to the proportion for 20min by a mixing machine to obtain the additive for improving the urinary calculus of the dog.
Example 4
The embodiment provides an additive for improving canine urinary tract stones, which comprises the following components in parts by weight:
30% of citric acid;
20% of lactic acid;
20% of burdock;
20% of lauric acid;
10% of a flow agent.
And (3) mixing the components of the additive weighed according to the proportion for 20min by a mixing machine to obtain the additive for improving the urinary calculus of the dog.
Example 5
The embodiment provides an additive for improving canine urinary tract stones, which comprises the following components in parts by weight:
30% of citric acid;
20% of lactic acid;
5% of burdock;
15% of lauric acid;
30 percent of flow agent.
And (3) mixing the components of the additive weighed according to the proportion for 20min by a mixing machine to obtain the additive for improving the urinary calculus of the dog.
Example 6
The embodiment provides an additive for improving canine urinary tract stones, which comprises the following components in parts by weight:
30% of citric acid;
20% of lactic acid;
15% of burdock;
5% of lauric acid;
30 percent of flow agent.
Comparative example 1
The comparative example provides an additive for improving canine urinary tract calculus, which comprises the following components in parts by weight:
5% of citric acid;
5% of lactic acid;
30% of burdock;
20% of lauric acid;
40% of a flow agent.
And (3) mixing the components of the additive weighed according to the proportion for 20min by a mixing machine to obtain the additive for improving the urinary calculus of the dog.
And (3) effect testing:
test 112 normal dogs were selected and fed the diets prescribed for the urinary tract of dogs of comparative example 1 and example 2 at intervals for 2 weeks. Urine was collected at the beginning and end of the test, and the change in pH and urine specific gravity before and after the test was compared. Aims to test the urine acidification effect. The interval feeding comprises feeding control daily ration without adding such functional bag, has no urine acidification effect, feeding comparative example 1 after feeding blank for 2 weeks, and feeding example 2 to reduce individual difference of animals in the same batch, wherein the blank feeding prevents the comparative example and the example from influencing each other
Test 1: the test conditions were as follows
TABLE 1 Canine basic information for trial 1
TABLE 2 dog urine pH comparison after feeding of two dog foods in test 1
Note: the difference of the lower case letters on the shoulders indicates that P is less than 0.05, and the difference is obvious; capital letters indicate P <0.01, and the difference is extremely significant
TABLE 3 dog urine specific gravity comparison after test 1 feeding of two diets
Note: the difference of the lower case letters on the shoulders indicates that P is less than 0.05, and the difference is obvious; capital letters indicate P <0.01, and the difference is extremely significant
The test 1 results are shown in tables 2 and 3, after the dog fed the prescription food for urinary tract of the dog in the comparative example 1 (negative control) for 2 weeks, the pH value of urine of the dog is not obviously reduced, and the expected preferable pH value of the urine which does not reach the prescription food for urinary tract calculus is 6.1-6.4; after the dog fed the prescription food for urinary tract of the dog in example 2 for 2 weeks, the pH value of urine of the dog is remarkably reduced, and the expected effect is achieved. The urine specific gravity of the dogs is not obviously different before and after the test, which indicates that the kidney function of the dogs is normal.
Experiment 2 dogs with 5 urinary tract crystals/stones were selected and fed with the urinary tract formula of the dogs of example 2 for 1 month, and bladder B-ultrasonic examination was performed at the beginning and end of the experiment, respectively. The pH value of the urine is acidic, which is beneficial to the crystallization and dissolution of magnesium ammonium phosphate and can prevent the recurrence of magnesium ammonium phosphate and calcium oxalate calculus. The pet hospital test conditions are as shown in fig. 1 and 2, and the entrusted test hospital: shanghai agricultural animal Hospital.
The test 2 dogs were examined and compared for cystocrystallization/calculi. The B ultrasonic condition is shown in figure 1 and figure 2, when the test is started, a B ultrasonic image in the light of No. 1 dog has a visible obvious bright spot which is calculus; the intravesical B-mode ultrasound image of dog No. 2 was seen as a continuous concentrated bright spot, which was crystalline. After removing the calculus, the No. 1 dog is fed with the prescription grain for urinary tract of the dog (example 2) for 1 month, and then bladder B ultrasonic detection is carried out again, and the shadow in the bladder is clean; no. 2 dog had no operation, and after 1 month of feeding the same grain, the bright spots in the bladder disappeared, the shade was clean, and the urine crystals had been dissolved.
The foregoing description of specific embodiments of the present invention has been presented. It is to be understood that the present invention is not limited to the specific embodiments described above, and that various changes and modifications may be made by one skilled in the art within the scope of the appended claims without departing from the spirit of the invention.
Claims (10)
1. An additive for improving urinary calculus of pets, which is characterized by comprising the following components: citric acid, lactic acid, fructus Arctii, medium-chain fatty acid, and flowing agent.
3. additive according to claim 1, wherein the medium-chain fatty acid is a fatty acid with 6 to 12 carbon atoms.
4. The additive according to claim 1, wherein the medium-chain fatty acid is one or more of lauric acid, caprylic acid, capric acid and caproic acid.
5. Additive according to claim 1, wherein said dispersing agent is silica.
6. A method for preparing the additive of claim 1, comprising the steps of:
s1, weighing the components of the additive according to the proportion;
s2, mixing the components to obtain the additive for improving the urinary calculus of the pet.
7. The method for preparing the additive according to claim 6, wherein the mixing time is 15 to 30 min.
8. A pet food comprising the additive of claim 1.
9. The pet food of claim 8, wherein the additive is present in an amount of 1-2% by weight of the pet food.
10. The pet food of claim 8, wherein the pet is a cat or a dog.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111197710.4A CN113940388A (en) | 2021-10-14 | 2021-10-14 | Additive for improving pet urinary calculus and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111197710.4A CN113940388A (en) | 2021-10-14 | 2021-10-14 | Additive for improving pet urinary calculus and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113940388A true CN113940388A (en) | 2022-01-18 |
Family
ID=79330443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111197710.4A Pending CN113940388A (en) | 2021-10-14 | 2021-10-14 | Additive for improving pet urinary calculus and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113940388A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101653379A (en) * | 2008-08-22 | 2010-02-24 | 天津生机集团股份有限公司 | Method for predicting type of formed calculi of canine cat daily rations |
CN101664439A (en) * | 2008-09-02 | 2010-03-10 | 天津生机集团股份有限公司 | Medicinal health agent for preventing and treating canine urinary calculi |
CN101721642A (en) * | 2008-11-03 | 2010-06-09 | 颜奎峰 | Medicine for treating calculus of urinary system and preparation method thereof |
CN104146185A (en) * | 2014-08-28 | 2014-11-19 | 甘肃农业大学 | Lamb concentrate supplement feed capable of preventing urinary calculus and preparation method thereof |
CN106578415A (en) * | 2016-11-16 | 2017-04-26 | 浙江日出生物科技有限公司 | Feed additive containing organic acid salts and medium-chain fatty acid compounds |
CN108783003A (en) * | 2018-06-29 | 2018-11-13 | 佛山市南海东方澳龙制药有限公司 | With the composition and preparation method thereof for adjusting animal functions of intestines and stomach |
CN112189755A (en) * | 2020-10-10 | 2021-01-08 | 上海福贝宠物用品股份有限公司 | Prescription grain nutrition scheme for improving urinary calculus of cat |
-
2021
- 2021-10-14 CN CN202111197710.4A patent/CN113940388A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101653379A (en) * | 2008-08-22 | 2010-02-24 | 天津生机集团股份有限公司 | Method for predicting type of formed calculi of canine cat daily rations |
CN101664439A (en) * | 2008-09-02 | 2010-03-10 | 天津生机集团股份有限公司 | Medicinal health agent for preventing and treating canine urinary calculi |
CN101721642A (en) * | 2008-11-03 | 2010-06-09 | 颜奎峰 | Medicine for treating calculus of urinary system and preparation method thereof |
CN104146185A (en) * | 2014-08-28 | 2014-11-19 | 甘肃农业大学 | Lamb concentrate supplement feed capable of preventing urinary calculus and preparation method thereof |
CN106578415A (en) * | 2016-11-16 | 2017-04-26 | 浙江日出生物科技有限公司 | Feed additive containing organic acid salts and medium-chain fatty acid compounds |
CN108783003A (en) * | 2018-06-29 | 2018-11-13 | 佛山市南海东方澳龙制药有限公司 | With the composition and preparation method thereof for adjusting animal functions of intestines and stomach |
CN112189755A (en) * | 2020-10-10 | 2021-01-08 | 上海福贝宠物用品股份有限公司 | Prescription grain nutrition scheme for improving urinary calculus of cat |
Non-Patent Citations (1)
Title |
---|
娄红军等: "58例犬鸟粪石尿结石的诊疗", 《畜牧与兽医》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Glade et al. | Enhanced nitrogen retention in yearling horses supplemented with yeast culture | |
CN100429991C (en) | Feed for weaned piglet | |
CN101869221B (en) | Feed additive for improving reproductive capacity of sow and preparation method thereof | |
CN108450672B (en) | Compound feed for sows in perinatal period and preparation method thereof | |
CN110122680A (en) | A kind of addition Herba Origani Vulgaris quintessence oil reduces the preparation method of mastitis for milk cows disease incidence feed | |
JP2023024222A (en) | Hairball remedy paste for cats | |
Agunbiade et al. | Performance characteristics of weaner rabbits on cassava peel-based balanced diets | |
Nutrition | Molasses in beef nutrition | |
O'Kelley et al. | Effects of feeding different magnesium levels to drylot-fed gestating beef cows | |
CN112189755A (en) | Prescription grain nutrition scheme for improving urinary calculus of cat | |
Fontenot | Animal nutrition aspects of grass tetany | |
CN113940388A (en) | Additive for improving pet urinary calculus and preparation method and application thereof | |
Khan et al. | Effect of replacing Til oil cake by poultry excreta on growth and nutrient utilization in growing bull calves | |
Wadhwa et al. | urea-molasses-multinutrient blocks/licks: a blend of nutrients for ruminants | |
CN112841423A (en) | Elk breeding feed and preparation method thereof | |
Reid Jr | Exploring duckweed (Lemna gibba) as a protein supplement for ruminants using the boer goat (Capra hircus) as a model | |
Playne | Effects of sodium sulpate and gluten supplements on the intake and digestibility of a mixture of spear grass and Townsville lucerne hay by sheep | |
Menezes et al. | Effects of sun-dried Opuntia ficus-indica on feed and water intake and excretion of urine and faeces by Dorper sheep | |
Summers et al. | Cellulolytic interrelationships of carbohydrates, fat and trace minerals in sheep rations | |
Kea et al. | Feed intake, digestibility and N retention of a diet of water spinach supplemented with palm oil and/or broken rice and dried fish for growing pigs | |
CN1757306B (en) | Forage additive made from traditional Chinese herb medicines, and its prepn. method | |
Bhinda et al. | Effect of shatavari (Asparagus racemosus) supplementation on intake, digestibility, growth and reproductive performance of crossbred heifers | |
DE2822272A1 (en) | ANIMAL FEED | |
Block et al. | Woodpulp fines of corn silage as roughages in complete rations or a pelleted complete ration for young dairy replacements from birth through 18 weeks of age | |
CN109938181A (en) | A kind of raising immunity of organisms compound pig feed and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220118 |
|
RJ01 | Rejection of invention patent application after publication |